CRIS Current Research Information System

RE, MARIA CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.136
EU - Europa 6.724
AS - Asia 5.771
AF - Africa 539
SA - Sud America 402
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 22.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.059
SG - Singapore 1.927
CN - Cina 1.541
IT - Italia 1.429
GB - Regno Unito 1.254
SE - Svezia 1.078
VN - Vietnam 1.076
DE - Germania 973
HK - Hong Kong 488
IN - India 373
RU - Federazione Russa 338
FR - Francia 285
BR - Brasile 279
IE - Irlanda 270
UA - Ucraina 260
NL - Olanda 259
TG - Togo 183
ZA - Sudafrica 109
CI - Costa d'Avorio 98
BG - Bulgaria 86
FI - Finlandia 86
EE - Estonia 84
JO - Giordania 81
NG - Nigeria 68
JP - Giappone 64
AR - Argentina 58
BE - Belgio 55
AT - Austria 51
SC - Seychelles 48
ID - Indonesia 47
CA - Canada 42
CH - Svizzera 42
KR - Corea 38
PL - Polonia 36
HR - Croazia 29
ES - Italia 22
MX - Messico 22
TR - Turchia 20
BD - Bangladesh 19
PT - Portogallo 19
IR - Iran 18
EC - Ecuador 16
AU - Australia 15
CL - Cile 15
LT - Lituania 14
RO - Romania 12
UZ - Uzbekistan 12
LB - Libano 11
CO - Colombia 9
PY - Paraguay 9
CZ - Repubblica Ceca 7
EG - Egitto 7
GR - Grecia 7
MY - Malesia 7
KZ - Kazakistan 6
PH - Filippine 6
DK - Danimarca 5
IL - Israele 5
LY - Libia 5
PK - Pakistan 5
BO - Bolivia 4
EU - Europa 4
HN - Honduras 4
HU - Ungheria 4
IQ - Iraq 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PE - Perù 4
RS - Serbia 4
TH - Thailandia 4
TW - Taiwan 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
ET - Etiopia 3
MA - Marocco 3
MK - Macedonia 3
PA - Panama 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
CM - Camerun 2
DO - Repubblica Dominicana 2
KE - Kenya 2
SA - Arabia Saudita 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AQ - Antartide 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
DZ - Algeria 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
GT - Guatemala 1
KW - Kuwait 1
Totale 22.582
Salva come PNG Salva come JPEG
Città #
Singapore 1.237
Southend 1.082
Ashburn 999
Fairfield 909
Chandler 736
Ann Arbor 497
Santa Clara 491
Hong Kong 477
Woodbridge 433
Seattle 423
Houston 412
Dong Ket 410
Wilmington 372
Princeton 337
Cambridge 327
Beijing 274
Dublin 270
Bologna 254
Boardman 209
Lomé 183
Frankfurt am Main 168
Ho Chi Minh City 157
Hanoi 151
Jacksonville 147
Westminster 130
Nanjing 128
Berlin 109
Los Angeles 101
Abidjan 98
Hefei 96
Padova 94
Milan 91
Turin 90
Redmond 84
Sofia 82
Amman 81
Dallas 72
Florence 69
San Diego 68
Jinan 66
New York 66
Redondo Beach 65
Des Moines 64
Abeokuta 63
Buffalo 62
Tokyo 57
Shenyang 56
Helsinki 54
Munich 53
Saint Petersburg 53
Brussels 52
Bremen 51
Hebei 46
Rome 41
Phoenix 40
Shanghai 39
Tianjin 37
Chicago 36
Seoul 36
São Paulo 33
Guangzhou 32
Nanchang 32
London 31
Mülheim 31
Changsha 30
Nuremberg 30
Dearborn 29
Falls Church 29
Olalla 29
Vienna 29
Bern 28
Jakarta 28
Redwood City 28
Zhengzhou 27
Falkenstein 25
Paris 23
Yubileyny 23
Hangzhou 22
Ningbo 22
Warsaw 22
Verona 20
Bühl 19
Jiaxing 19
Monmouth Junction 19
Bengaluru 18
Haiphong 18
Atlanta 17
Lanzhou 16
Stockholm 16
Taiyuan 16
Toronto 16
Brooklyn 15
Lappeenranta 15
Mahé 15
Naples 15
San Francisco 15
Turku 15
Wuhan 15
Biên Hòa 14
Haikou 14
Totale 14.295
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 311
ALTERAZIONI DEL MICROBIOMA FARINGEO IN CORSO DI INFEZIONI DA NEISSERIA GONORRHOEAE 300
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff? 296
Analisi della trasmissione di SARS-CoV-2: influenza delle condizioni termoigrometriche rispetto al rischio di diffusione del contagio 287
RILEVAZIONE DELLA STRUTTURA MOSAICO DEL GENE PENA IN SEDE ORO-FARINGEA 242
Restriction Factors expression decreases in HIV-1 patients after cART 232
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 231
Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: a hallmark of autoimmune disease? 224
Acute onset myopericarditis as unusual presentation of primary HIV infection 220
Impact of meropenem on Klebsiella pneumoniae metabolism 217
Pharyngeal Chlamydia and gonorrhea: a hidden problem 215
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells 214
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. 213
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection 211
Discordant resistance interpretations in multi-treated HIV-1 patients 211
Comparison of the Aptima HIV-1 Quant Dx Assay with the COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 v2.0 Test for HIV-1 Viral Load Quantification in Plasma Samples from HIV-1-Infected Patients. 206
Mosaic structure of the penA gene in the oropharynx of men who have sex with men negative for gonorrhoea 200
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 196
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 195
IFI16 expression is related to selected transcription factors during B-cell differentiation 194
Autochthonous cases of mucosal leishmaniasis in Northeastern Italy: clinical management and novel treatment approaches 186
HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients. 178
Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples 178
Pre-Pregnancy Diet and Vaginal Environment in Caucasian Pregnant Women: An Exploratory Study 178
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 176
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 171
Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cells 170
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 169
Asymptomatic Leishmania infantum infection in blood donors living in an endemic area, northeastern Italy 169
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 169
Effects of Antiretroviral Molecules on Survival and Gene Expression of an Osteoblast-like Cell Line 167
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 167
Pharyngeal microbiome alterations during Neisseria gonorrhoeae infection 165
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures 165
Antiretroviral molecules and cardiovascular diseases. 164
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures. 161
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 161
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 161
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 158
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 156
Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects. 155
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 155
Pharyngeal chlamydia and gonorrhoea: a hidden problem. 154
HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR. 153
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 153
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 153
Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy. 153
SARS-CoV-2/COVID-19 testing: The tower of babel 153
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 153
Subgingival periodontal pathogens in Down syndrome children without periodontal breakdown. A case-control study on deciduous teeth 153
Detection of serum antibodies to human intracisternal A-type retroviral particles in chronic idiopathic urticaria 151
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 151
Host restriction factors and Human immunodeficiency Virus (HIV-1): a dynamic interplay involving all phases of the viral life cycle 150
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 149
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz 149
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. 148
High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method. 148
Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients. 148
Rectal Microbiota Associated With Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Having Sex With Other Men 148
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy 147
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): A three year study 147
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 147
Guidelines for the qualitative detection of viral genomes in dried blood spots. 146
Different patterns of HIV-1 DNA after therapy discontinuation 146
Bone alterations during HIV infection 146
Cap. 4- IL MICROBIOMA OCULARE E IMPATTO SUL SISTEMA IMMUNE 146
Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy. 145
Validation of a Cleanroom Compliant Sonication-Based Decellularization Technique: A New Concept in Nerve Allograft Production 144
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise 144
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy 143
HIV-1 subtype C transmission network: The phylogenetic reconstruction strongly supports the epidemiological data. 143
HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report. 142
HIV and kidney: A dangerous liaison 142
HIV-related mechanisms in atherosclerosis and cardiovascular diseases. 141
Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results 141
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 141
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 140
An imported case of adult T cell leukemia in a HTLV-I-infected patient in Italy. 140
Comparison of MycoPrep and the new MYCO-TB kit: rapid and efficient digestion and decontamination of respiratory specimens for the detection of Mycobacteria 140
Total integration of cultural and molecular testing for CPE screening with liquid based microbiology (LBM) 140
Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection. 139
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients 138
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 137
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 137
HIV-1 tat protein and cell proliferation and survival: a brief review. 136
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice 136
Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates 136
Antiretroviral Activity of Thiosemicarbazone Metal Complexes 135
Nevirapine prophylaxis to prevent HIV-1 mother-to-child transmission: pharmacokinetic considerations in preterm infants 135
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 135
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 135
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 134
Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. 133
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 133
Durable viral suppression in an HIV-infected patient in the absence of antiretroviral therapy 132
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection 131
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation. 131
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 131
Effect of sugars on Chlamydia trachomatis infectivity 131
A large outbreak of giardiasis in a municipality of the Bologna province, north-eastern Italy, november 2018 to april 2019 131
Totale 16.558
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.691 0 0 0 0 0 140 47 130 312 170 127 765
2021/20223.542 245 194 205 414 295 188 73 228 132 463 630 475
2022/20233.753 398 525 219 508 286 241 106 219 617 136 321 177
2023/20241.065 74 166 83 119 89 219 70 71 22 71 40 41
2024/20253.874 163 607 312 289 665 223 235 132 64 339 151 694
2025/20263.804 721 653 607 590 1.000 233 0 0 0 0 0 0
Totale 23.129